Medical Imaging Corp. (MEDD) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMedical Imaging Corp. (MEDD) trades at $0.0002. Medical Imaging Corp. provides medical diagnostic imaging services to patients, hospitals, clinics, workers' compensation boards, and insurance companies. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for MEDD: MEDD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Medical Imaging Corp. (MEDD) Healthcare & Pipeline Overview
Medical Imaging Corp. delivers diagnostic imaging services, including MRI, CT, and ultrasound, primarily in North America. Operating diagnostic centers and offering remote reading services, the company caters to patients, hospitals, and insurance providers. With a negative profit margin and OTC market listing, MEDD faces significant financial and market challenges.
What Is the Investment Thesis for MEDD?
Medical Imaging Corp. operates in the diagnostic imaging services sector, facing both opportunities and challenges. The company's comprehensive range of imaging modalities and services, including remote reading and reporting, positions it to serve a broad client base. However, its negative profit margin of -41.8% and lack of dividend payments raise concerns about financial sustainability. Trading on the OTC market introduces additional risks related to liquidity and regulatory oversight. Growth catalysts could include expanding its geographic footprint and forming strategic partnerships with hospitals and clinics. Investors should carefully consider the company's financial performance, market position, and OTC listing before making investment decisions. The high beta of 6.12 indicates high volatility.
Based on FMP financials and quantitative analysis
MEDD Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -0.00 reflects the company's lack of profitability.
- Profit margin of -41.8% suggests significant operational inefficiencies and cost management challenges.
- Gross margin of 15.1% indicates a limited ability to generate profit from its services after accounting for direct costs.
- Beta of 6.12 suggests the stock is significantly more volatile than the market.
Who Are MEDD's Competitors?
What Are MEDD's Key Strengths?
Comprehensive range of diagnostic imaging services.
- Remote reading and reporting capabilities.
- Established relationships with hospitals and clinics.
- Experience in serving workers' compensation boards and insurance companies.
What Are MEDD's Weaknesses?
Negative profit margin.
- Limited market capitalization.
- OTC market listing.
- Dependence on a small number of diagnostic centers.
What Are the Key Risks for MEDD?
Negative profit margin of -41.8% raises concerns about financial sustainability and the ability to fund future growth.
- Intense competition in the diagnostic imaging market may limit the company's ability to gain market share and maintain pricing.
- Regulatory changes and reimbursement policies could negatively impact revenue and profitability.
- OTC market listing introduces risks related to liquidity, transparency, and regulatory oversight.
- Technological obsolescence could render the company's imaging equipment and services outdated.
What Are MEDD's Competitive Advantages?
- Established relationships with hospitals and clinics.
- Comprehensive range of imaging modalities.
- Remote reading and reporting capabilities.
- Experience in serving workers' compensation boards and insurance companies.
What Does MEDD Do?
Medical Imaging Corp., formerly known as Diagnostic Imaging International Corp., was founded in 2000 and rebranded in July 2014. Headquartered in Las Vegas, Nevada, the company focuses on providing medical diagnostic imaging services. These services include remote reading and reporting of medical diagnostic imaging scans, catering to a diverse clientele including patients, hospitals, clinics, workers' compensation boards, and insurance companies across North America. The company offers a comprehensive suite of imaging modalities, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of December 31, 2017, Medical Imaging Corp. operated an independent diagnostic imaging facility in Pottsville, Pennsylvania, and three diagnostic centers in Florida. The company's business model centers on delivering timely and accurate diagnostic imaging services, bridging the gap between imaging technology and patient care. However, the company faces challenges, including a negative profit margin and trading on the OTC market, which may impact its growth and stability.
What Products and Services Does MEDD Offer?
- Provides remote reading and reporting of medical diagnostic imaging scans.
- Offers magnetic resonance imaging (MRI) services.
- Provides computed tomography (CT) services.
- Offers positron emission tomography (PET) services.
- Provides ultrasound services.
- Offers nuclear medicine services.
- Provides digital mammography services.
- Offers X-ray services.
- Provides bone mineral densitometry modalities.
How Does MEDD Make Money?
- Provides diagnostic imaging services to patients, hospitals, and clinics.
- Generates revenue through fees for imaging scans and reporting services.
- Contracts with workers' compensation boards and insurance companies for imaging services.
- Operates diagnostic imaging facilities and centers.
What Industry Does MEDD Operate In?
Medical Imaging Corp. operates within the medical diagnostics and research industry, a sector experiencing growth driven by technological advancements and an aging population. The market is competitive, with established players and smaller firms vying for market share. Key trends include the increasing adoption of advanced imaging technologies, the rise of teleradiology, and the growing demand for diagnostic services. Medical Imaging Corp. competes with companies offering similar imaging services, facing pressure to innovate and maintain competitive pricing. The industry is also subject to regulatory oversight and reimbursement policies, impacting profitability and market access.
Who Are MEDD's Key Customers?
- Patients requiring diagnostic imaging services.
- Hospitals and clinics seeking outsourced imaging services.
- Workers' compensation boards requiring imaging for injured workers.
- Insurance companies needing imaging for claims processing.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Medical Imaging Corp. operates in the Healthcare sector. It is headquartered in Las Vegas, United States.
Key Financial Metrics
Return on equity for Medical Imaging Corp. stands at 73.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -72.1%, showing how much profit it generates from its asset base. Its free cash flow yield is -96.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching.
MEDD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
MEDD Latest News
-
VALOR Network Selects RADIN™ Health to Power Federal Teleradiology Services, with Total Medical Imaging Providing Nationwide Physician Coverage
Yahoo! Finance: MEDD News · Sep 1, 2026
MEDD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MEDD.
Price Targets
Wall Street price target analysis for MEDD.
MEDD MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MEDD; grades run from A+ (80-100) to F (below 30).
Leadership: Mitchell Geisler
CEO
Mitchell Geisler serves as the CEO of Medical Imaging Corp., overseeing the company's strategic direction and operations. His background includes experience in managing teams and implementing growth strategies. He is responsible for guiding the company's efforts in providing diagnostic imaging services and expanding its market presence. Geisler's leadership is focused on driving innovation and improving patient outcomes through advanced imaging technologies.
Track Record: Under Mitchell Geisler's leadership, Medical Imaging Corp. has focused on maintaining its existing diagnostic centers and exploring opportunities for expansion. Key milestones include efforts to enhance the company's teleradiology capabilities and strengthen relationships with hospitals and clinics. Geisler has also emphasized the importance of investing in advanced imaging technologies to improve the accuracy and efficiency of diagnostic services.
MEDD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Medical Imaging Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available and may be subject to greater risks. Trading on the OTC Other tier typically involves less stringent listing requirements compared to major exchanges like the NYSE or NASDAQ, resulting in reduced transparency and investor protection.
- OTC Tier: OTC Other
- Limited financial disclosure increases the risk of investing in Medical Imaging Corp.
- Low trading volume and liquidity can lead to significant price volatility.
- OTC Other tier listing indicates a higher risk of fraud or mismanagement.
- Lack of regulatory oversight compared to major exchanges.
- Potential for delisting or trading suspension due to non-compliance.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue and profitability trends.
- Check for any legal or regulatory issues.
- Monitor news and press releases for any significant developments.
- Consult with a financial advisor before investing.
- Company has been in operation since 2000.
- Provides essential diagnostic imaging services.
- Operates diagnostic facilities in multiple states.
- CEO is identified and managing the company.
- Company has a history of providing services to patients, hospitals, and insurance companies.
MEDD Healthcare Stock FAQ
What does Medical Imaging Corp. do?
Medical Imaging Corp. provides a range of diagnostic imaging services, including MRI, CT scans, and X-rays, to patients, hospitals, and clinics.
What do analysts say about MEDD stock?
As of March 18, 2026, there is no readily available analyst coverage or consensus on Medical Imaging Corp. (MEDD) due to its OTC listing and limited market capitalization. Key valuation metrics, such as P/E ratio (-0.00) and profit margin (-41.8%), reflect the company's current financial challenges.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Financial data is limited to information available as of December 31, 2017.
- OTC market data may be less reliable than data from major exchanges.